【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding disease
• Types of prostate cancer
• Diagnosis
• Key buying criteria
PART 06: Pipeline analysis
PART 07: Market landscape
• Global prostate cancer therapeutics market
• Five forces analysis
PART 08: Market segmentation by therapy
• Hormonal therapy
• Chemotherapy
• Immunotherapy
• Targeted therapy
PART 09: Geographical segmentation
• Global prostate cancer drugs market by geographical segmentation 2015-2020
• Prostate cancer drugs market in Americas
• Prostate cancer drugs market in EMEA
• Prostate cancer drugs market in APAC
PART 10: Market drivers
• Physicians preference toward adopting hormonal therapies
• Development of drugs with novel mechanism of action
• Availability of large patient pool
PART 11: Impact of drivers
PART 12: Market challenges
• Presence of alternative treatment approaches
• High cost of drugs
• Adverse side-effects of drugs
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor analysis
Johnson & Johnson
• Astellas Pharma
• AstraZeneca
• Sanofi
• AbbVie
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments of global prostate cancer drugs market
Exhibit 03: Snapshot of prostate cancer
Exhibit 04: Types of prostate cancer
Exhibit 05: Main diagnostic procedures to determine presence of prostate cancer
Exhibit 06: Key buying criteria for prostate cancer drugs
Exhibit 07: Factors affecting the adoption rates of prostate cancer drugs 2015 and 2020
Exhibit 08: Pipeline analysis of key vendors in global prostate cancer drugs market
Exhibit 09: Percentage share of drug candidates by stage of development
Exhibit 10: Phase III pipeline portfolio: Global prostate cancer drugs market
Exhibit 11: Phase II pipeline portfolio: Global prostate cancer drugs market
Exhibit 12: Phase I pipeline portfolio: Global prostate cancer drugs market
Exhibit 13: Global prostate cancer therapeutics market snapshot
Exhibit 14: Analysis of global prostate cancer therapeutics market
Exhibit 15: Pipeline of global prostate cancer drugs
Exhibit 16: Global prostate cancer drugs market 2015-2020 ($ billions)
Exhibit 17: Opportunity analysis of global prostate cancer drugs market
Exhibit 18: Opportunity analysis in developed and emerging markets
Exhibit 19: Five forces analysis
Exhibit 20: Segmentation of global prostate cancer drugs market by therapy 2015
Exhibit 21: Life cycle analysis of key segments in global prostate cancer drugs market
Exhibit 22: Analysis of prostate cancer drugs market by geography
Exhibit 23: Segmentation of prostate cancer drugs market based on geography 2015 and 2020
Exhibit 24: Prostate cancer drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 25: Prostate cancer drugs market size and forecast in Americas 2015-2020 ($ billions)
Exhibit 26: Key trends across various countries in Americas
Exhibit 27: Incidence of prostate cancer in key countries of EMEA 2012
Exhibit 28: Prostate cancer drugs market size and forecast in EMEA 2015-2020 ($ billions)
Exhibit 29: Trends in prostate cancer therapeutics market in EMEA
Exhibit 30: Prostate cancer drugs market in APAC 2015-2020 ($ billions)
Exhibit 31: Key drivers and challenges in APAC
Exhibit 32: Performance of hormone therapies in 2015
Exhibit 33: Key drugs with novel mechanism of action
Exhibit 34: Potential older population with prostate cancer (65 years and above)
Exhibit 35: Impact of drivers
Exhibit 36: Alternative therapies
Exhibit 37: Costs of key prostate cancer drugs ($ thousands)
Exhibit 38: Some of the side-effects of drugs
Exhibit 39: Force field analysis of drivers and challenges in global prostate cancer drugs market
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Trend analysis in global prostate cancer drugs market
Exhibit 42: Key highlights of targeted therapies and immunotherapies
Exhibit 43: New advancements in diagnosis of prostate cancer
Exhibit 44: Key late stage pipeline candidates
Exhibit 45: Competitive structure analysis of global prostate cancer drugs market 2015
Exhibit 46: Market share analysis 2015
Exhibit 47: Performance/initiatives of existing and upcoming vendors in global prostate cancer drugs market
Exhibit 48: Competitive analysis in global prostate cancer therapeutics market
Exhibit 49: Market penetration of various prostate cancer drug manufacturers worldwide 2015
Exhibit 50: Regional analysis of vendors in global prostate cancer drugs market
Exhibit 51: Johnson & Johnson: Key highlights
Exhibit 52: Johnson & Johnson: Strength assessment
Exhibit 53: Johnson & Johnson: Strategy assessment
Exhibit 54: Johnson & Johnson: Opportunity assessment
Exhibit 55: Johnson & Johnson: YoY revenue comparison of Zytiga (Global) 2013-2015 ($ billions)
Exhibit 56: Astellas Pharma: Key highlights
Exhibit 57: Astellas Pharma: Strength assessment
Exhibit 58: Astellas Pharma: Strategy assessment
Exhibit 59: Astellas Pharma: Opportunity assessment
Exhibit 60: Astellas Pharma: YoY revenue comparison of Xtandi 2014-2015 ($ billions)
Exhibit 61: AstraZeneca: Key highlights
Exhibit 62: AstraZeneca: Strength assessment
Exhibit 63: AstraZeneca: Strategy assessment
Exhibit 64: AstraZeneca: Opportunity assessment
Exhibit 65: AstraZeneca: YoY revenue and growth rate of Zoladex 2013-2015 ($ millions)
Exhibit 66: AstraZeneca: Geographic segmentation of Zoladex 2015
Exhibit 67: AstraZeneca: YoY revenue and growth rate of Casodex 2013-2015 ($ millions)
Exhibit 68: AstraZeneca: Geographic segmentation of Zoladex 2015
Exhibit 69: Sanofi: Key highlights
Exhibit 70: Sanofi: Strength assessment
Exhibit 71: Sanofi: Strategy assessment
Exhibit 72: Sanofi: Opportunity assessment
Exhibit 73: Sanofi: YoY revenue and growth rate of Jevtana 2013-2015 ($ millions)
Exhibit 74: Sanofi: YoY revenue and growth rate of Taxotere 2013-2015 ($ millions)
Exhibit 75: AbbVie: Key highlights
Exhibit 76: AbbVie: Strength assessment
Exhibit 77: AbbVie: Strategy assessment
Exhibit 78: AbbVie: Opportunity assessment
Exhibit 79: AbbVie: YoY revenue and growth rate of Lupron 2013-2015 ($ millions)
【レポート販売概要】
■ タイトル：前立腺がん治療薬の世界市場2016-2020：ホルモン療法、化学療法、免疫療法、標的治療■ 英文：Global Prostate Cancer Drugs Market 2016-2020
■ 発行日：2016年11月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10968
■ 調査対象地域：グローバル
- Malnutrition：グローバル臨床試験レビューH1, 2013Malnutrition Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Malnutrition Global Clinical Trials Review, H1, 2013" provides data on the Malnutrition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malnutrition. It includes an overview of the trial numbers and their recruitment status as per the sit …
- スマートグリッド市場まとめ2012Smart Grid Round-Up 2012 Summary GlobalData announces the release of its annual smart grid round-up 2012 from the Smart Grid eTrack. The newsletter provides update on the global developments related to smart grid deployment across the globe during the year 2012. Scope - Market prospect for companies providing smart grid systems in 2012 - Key product launch in power grids in 2012 - Major news and d …
- 組織診断の世界市場予測（～2022年）：消耗品、装置、技術、疾患、エンドユーザー“Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period”The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technologica …
- 高級アイウェアの世界市場2019-2023About this market Growing trend for personalized luxury eyewear to drive market growth. The desire for premium eyeglasses and sunglasses among potential customers is growing in European countries such as Germany, the UK, France, Spain, and Italy. Some of the popular premium brands of sunglasses are sold by LVMH. LUXOTTICA GROUP. Safilo Group, and Essilor. Despite low volume sales relative to the m …
- 炭素繊維強化プラスチック（CFRP）複合材料の世界市場The consumption of carbon fibre reinforced composites has increased significantly in recent years and is expected to grow at a more rapid pace during the coming decade. The CFRP composites market has been dominated by North America, accounting for over a third of the global market. However, we expect the European and Asian regions to expand more rapidly, where growth rates perform above the global …
- 2014年戦略提言：日本の診断市場This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood Banking - Cancer - Chemistry & …
- 腰＆膝再建装置の世界市場2015-2022According to Stratistics MRC, the Hip and Knee Reconstruction market accounted for $18.3 billion in 2015 and is expected to grow at a CAGR of 11.19% to reach $38.46 billion by 2022. The factors such as increase in the occurrence of osteoporosis in aging population, increasing number of obesity cases and raising multiple advancements in hip and knee reconstructive products, are some of the factors …
- 世界の腎透析装置市場2015The Global Renal Dialysis Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Renal Dialysis Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Renal Dialysis Equipment market analysis is provided for the international markets inclu …
- 転移性卵巣癌：グローバル臨床試験レビュー（2014年上半期）Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Ovarian Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Ovarian Cancer. It includes an overview of the trial …
- グローバル旅行・観光産業の景況感レポート（2015年上半期）Summary “Travel and Tourism Industry Business Outlook and Procurement Report H1 2015” is a new report by Canadean that globally analyzes top priorities, key emerging and developed markets. Top procurement areas, future budgets and supplier price outlooks are also covered. Key Findings - 'Improving operational efficiency' and 'expand in current market' are key priorities for travel and tourism orga …
- 海上地震探査装置及びデータ取得の世界市場Overall, spending on marine seismic equipment and acquisition will fall significantly in 2015 after the oil price collapse and then gradually recover in line with oil prices. However it will take years to reach CAPEX levels witnessed in 2014. Visiongain has calculated that in 2015 the global marine seismic equipment market is worth $784.3m and the global acquisition market is worth $4,601.6m. What …
- インドの遠隔医療市場2016-2020About the Remote Health Delivery Market in India Remote health delivery, or telemedicine, is defined as the remote delivery of healthcare services through ICT. It is an effective combination of ICT and medical science that helps address the challenges faced by the Indian healthcare delivery system. Remote health delivery shifts the focus of a healthcare system from curing diseases in hospitals to …
- 電圧/無効電力管理の世界市場予測（～2024年）“The volt/VAr management market is projected to grow at a CAGR of 5.9%, from 2019 to 2024.” The volt/VAr management market is projected to reach USD 568 million by 2024 from an estimated USD 427 million in 2019, at a CAGR of 5.9%. The need to reduce distribution losses & operational costs to optimize power factor, the increasing complexity of distributed energy generation, and the rising demand fo …
- 世界の軍事IT、データ、コンピューティング市場（2014-2024）：SWOT分析Synopsis This report provides readers with an exhaustive analysis of industry characteristics, determining the strengths, weaknesses, opportunities and threats faced by the Military IT, Data and Computing market. Summary This SWOT analysis of Military IT, Data and Computing market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's " …
- 世界の光ファイバー部品市場2015The Global Fiber Optic Components Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Fiber Optic Components industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Fiber Optic Components market analysis is provided for the international markets including d …
